Investigation of Non-alcoholic steatohepatitis development in newly designed short-term insulin resistance-fatty liver rat models. From chronic to acute

Author:

Mohammed Eman D.1,Sun Beicheng2

Affiliation:

1. Desert Research Center

2. The Affiliated Drum Tower Hospital of Nanjing University Medical School

Abstract

Abstract Background The progression of insulin resistance (IR) and diabetes into non-alcoholic steatohepatitis (NASH) is a chronic process. The pathogenesis of diabetes progression into NASH is very complex and not fully understood. The lack of reproducible IR-NASH animal models that mimic human pathogenesis is the main roadblock. Therefore, we designed this study to investigate the development of IR-NASH within one month using new combinations of diets, fructose, and a small dose of streptozotocin (MFD or HFD/HFrD/STZ). And compare them with the known IR-NASH model using HFD/STZ. Methods Thirty-two male Wistar rats were randomized into four different groups and fed by either a different combination of diets or a chow diet for one month. After two weeks, a single dose of STZ was injected in all groups except the healthy group to develop diabetes. Body weights, animal mortality, eating, and drinking behaviors were recorded during the study. Glucose intolerance, hepatotoxicity indices, and fat accumulation were investigated. Also, we examined the hepatic histopathological alternations in rats. Results Animals’ body weights, eating, and drinking behaviors were extremely affected in high fructose diet (HFrD)-feed groups. Also, all groups showed a significant IR and glucose intolerance. However, the clear progressive NASH with aggressive hepatic steatosis, inflammation, and fibrosis was visualized in the investigated liver sections’ of HFrD-feed groups only. At the same time, the HFD/STZ group showed progressive non-alcoholic fatty liver disease (NAFLD) only. Conclusion MFD or HFD/ HFrD/ STZ models were successful short-term NASH models that can be used for pharmacological screening studies and dose selection. While HFD/STZ is a suitable model for chronic pharmacological investigations.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3